Lung cancer trials in United Arab Emirates

1 trial · From ClinicalTrials.gov, checked 12 November 2026. Ask the study team whether a trial fits you.

• Phase 3Taking people
  Pembrolizumab With or Without Maintenance Sacituzumab Tirumotecan (Sac-TMT; MK-2870) in Metastatic Squamous Non-small Cell Lung Cancer (NSCLC) [MK-2870-023]

  Where

  Abu Dhabi

  Age

  18 years and over

  People

  851 worldwide

  Run by

  Merck Sharp & Dohme LLC

  See details and how to joinNCT06422143 · EU 2023-510128-66-00